- $95.19m
- $309.85m
- $100.91m
- 56
- 96
- 21
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 36.3 | 49 | 63.1 | 70.1 | 68.9 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 35.4 | 40.7 | 62 | 67.6 | 62.1 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 13.5 | 34.5 | 46.3 | 27.9 | 17 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.5 | 26.4 | 35.6 | 21.8 | 13.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.5 | 26.4 | 35.6 | 21.8 | 13.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.5 | 26.4 | 35.6 | 21.8 | 13.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.814 | 2.14 | 2.87 | 1.79 | 1.16 |
Dividends per Share | |||||
Special Dividends per Share |